| abstract |
The invention pertains to the field of human genetics and relates to new methods of diagnosis and therapy of type 2 diabetes (T2D), early onset type 2 diabetes and Maturity-Onset Diabetes of the Young (MODY) in a human subject, based on the identification of the A185G variation located at exon 2 of the tieg2 gene as well as the G-1534C, 54a, 304a, +659 C>T (Thr220Met) and +1039 G>T (Ala347Ser) variations. |